Vertex Pharmaceuticals Incorporated (BMV:VRTX)

Mexico flag Mexico · Delayed Price · Currency is MXN
8,300.29
+512.78 (6.58%)
At close: Dec 3, 2025
-11.36%
Market Cap 2.10T
Revenue (ttm) 215.03B
Net Income (ttm) 67.41B
Shares Out n/a
EPS (ttm) 260.87
PE Ratio 31.19
Forward PE 22.33
Dividend n/a
Ex-Dividend Date n/a
Volume 8
Average Volume 283
Open 8,300.29
Previous Close 7,787.51
Day's Range 8,300.29 - 8,300.29
52-Week Range 6,800.00 - 10,318.00
Beta 0.32
RSI 62.73
Earnings Date Feb 2, 2026

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 6,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.